Oncothyreon to Present at Future Leaders in the Biotech Industry Conference
SEATTLE, WA, March 29, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the 20th Annual Future Leaders in the Biotech Industry Conference, presented by BioCentury and Thomson Reuters, in New York on Friday, April 5, 2013 at 10:30 a.m. Eastern time.
A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
More by this Source
Oncothyreon Reports Full Year and Fourth Quarter 2013 Financial Results
Mar 13, 2014, 16:01 ET
Oncothyreon Announces Full Year and Fourth Quarter 2013 Financial Results Conference Call
Mar 06, 2014, 08:00 ET
Oncothyreon to Present at Cowen and Company 34th Annual Health Care Conference
Feb 26, 2014, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.